IMPAKT Breast Cancer Conference(esearch directly into their clinical wor...),Health

IMPAKT is more than just a breast cancer meeting. It represents a strong commitment by a growing and united alliance of European breast cancer groups, working together to keep pace with advances in translational research and their relevance for treating patients.

The meeting is being launched by the Breast International Group (BIG) and the European Society for Medical Oncology (ESMO), in collaboration with St. Gallen Primary Therapy of Early Breast Cancer Conference and the three European Breast Cancer Conference (EBCC) partners: The European Organisation for Research and Treatment of Cancer (EORTC), the European Society of Breast Cancer Specialists, and Europa Donna The European Breast Cancer Coalition. IMPAKT is also supported by the European School of Oncology (ESO).

"The meeting is a tangible proof that we are all committed to accelerating the transfer of scientific knowledge from the laboratory to the patient and back again," said Prof Piccart.

Other meeting highlights:

• New therapeutic strategies
• New markers of response to treatment
• Using gene expression to tailor treatment
• New imaging techniques to help guide therapy

'/>"/>